Utilisation of Lipid-Lowering Drugs in Spain between 1986 and 1998

Author： Carvajal A.   del Pozo J.G.   Rodríguez M.B.   Martín Arias L.H.   de Castro A.M.R.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.20, Iss.3, 2000-09, pp. : 197-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interactions Between Cyclosporin and Lipid-Lowering Drugs: Implications for Organ Transplant Recipients

By åsberg A.  

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 367-378

Adis International

Access to resources Recommend Favorite

New prospects for lipid-lowering drugs

By Thompson G.R.   Naoumova R.P.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 715-727

Informa Healthcare

Access to resources Recommend Favorite

Emerging lipid-lowering drugs: squalene synthase inhibitors

By Elsayed Raghda K   Evans Jeffery D  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite

Patients are less likely to receive lipid-lowering drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A New Class of Lipid-Lowering Drugs: Ezetimibe

By  

Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. : 214-216

Karger

Access to resources Recommend Favorite